Point72 Asset Management’s Mesa Laboratories MLAB Stock Holding History

Point72 Asset Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.44M	Buy	16,309 +2,851	+21%	+$246K	﹤0.01%	2523
2025 Q4	$1.06M	Buy	+13,458	New	+$1.02M	﹤0.01%	2840
2024 Q3	–	Sell	-7,841	Closed	-$680K	–	2210
2024 Q2	$680K	Sell	7,841 -12,925	-62%	-$1.35M	﹤0.01%	1365
2024 Q1	$2.28M	Buy	+20,766	New	+$2.09M	0.01%	1221
2023 Q3	–	Sell	-100	Closed	-$12.8K	–	2727
2023 Q2	$12.8K	Sell	100 -17,800	-99%	-$2.71M	﹤0.01%	1868
2023 Q1	$3.13M	Sell	17,900 -60,114	-77%	-$10.8M	0.01%	904
2022 Q4	$13M	Buy	78,014 +41,855	+116%	+$6.56M	0.04%	466
2022 Q3	$5.09M	Buy	+36,159	New	+$6.6M	0.02%	719

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $220M AUM 25.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Point72 Asset Management's MLAB Position: Q1 2026 in Review

Point72 Asset Management increased its Mesa Laboratories (MLAB) stake by 21% in Q1 2026, buying an estimated $246K and bringing the position to 16,309 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2523.

Point72 Asset Management first reported a position in MLAB in Q3 2022 and has held it in 8 quarters since. The position peaked at $13M in Q4 2022. 161 funds tracked by Wall St. Rank hold MLAB as of Q1 2026.

Point72 Asset Management held 16,309 shares of Mesa Laboratories worth $1.44M as of Q1 2026.
Point72 Asset Management bought 2,851 Mesa Laboratories shares in Q1 2026, an estimated $246K.
Mesa Laboratories made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2523 holding.
Point72 Asset Management first reported a position in Mesa Laboratories in Q3 2022 and has held it in 8 quarters since.
Point72 Asset Management's Mesa Laboratories position peaked at $13M in Q4 2022.
161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.